Transfusion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent plasma is a promising treatment for severe coronavirus disease 2019 (COVID-19) cases, with success of the intervention based on neutralizing antibody content. Measurement by serologic correlates without biocontainment needs as well as an understanding of donor characteristics that may allow for targeting of more potent donors would greatly facilitate effective collection.
Useful keywords (using NLM MeSH Indexing)
Enzyme-Linked Immunosorbent Assay
Find related publications in this database (Keywords)convalescent donor selection